Rodman David Malcom bought MLYS
January 5, 2026 · Form 4 insider transaction
Rodman David Malcom bought 67,473 shares of Mineralys Therapeutics, Inc. at $14.25 per share, a transaction worth $961.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
67,473
Price
$14.25
Total value
$961.5K
InsiderRodman David Malcom
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 5, 2026
Filing dateJanuary 6, 2026
Shares owned after254,519
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.